Replies to post #12725 on Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

Can't recall whether they are developing a generic on focalin or not bro...but the fact that Focalin's year over year sales really didn't decline DESPITE no longer enjoying their 180 day exclusivity window would sure seem to give the impression that not only is PAR still all in on IPCI's Focalin ANDA...they must be ramping up their commercialization endeavors this year as that's the only way to explain the surprising fact that they didn't lose any relevant market share despite no longer being under 180 days of exclusivity right!